Ad is loading...
CWGCX
Price
$67.30
Change
+$0.23 (+0.34%)
Updated
Nov 22 closing price
MWEMX
Price
$51.97
Change
+$0.30 (+0.58%)
Updated
Nov 22 closing price
Ad is loading...

CWGCX vs MWEMX

Header iconCWGCX vs MWEMX Comparison
Open Charts CWGCX vs MWEMXBanner chart's image
American Funds Capital World Gr&Inc C
Price$67.30
Change+$0.23 (+0.34%)
VolumeN/A
CapitalizationN/A
MFS Global Equity R6
Price$51.97
Change+$0.30 (+0.58%)
VolumeN/A
CapitalizationN/A
CWGCX vs MWEMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CWGCX vs. MWEMX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWGCX is a StrongBuy and MWEMX is a StrongBuy.

FUNDAMENTALS
Fundamentals
CWGCX has more cash in the bank: 126B vs. MWEMX (2.39B). CWGCX (1.04) and MWEMX (1.03) have matching dividends . CWGCX was incepted earlier than MWEMX: CWGCX (24 years) vs MWEMX (12 years). CWGCX is a more actively managed with annual turnover of: 27.00 vs. MWEMX (8.00). MWEMX has a lower initial minimum investment than CWGCX: MWEMX (0) vs CWGCX (250). CWGCX annual gain was more profitable for investors over the last year : 17.95 vs. MWEMX (5.93). CWGCX return over 5 years is better than : 37.99 vs. MWEMX (11.48).
CWGCXMWEMXCWGCX / MWEMX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years12 years-
Gain YTD13.5847.534180%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets126B2.39B5,263%
Annual Yield % from dividends1.041.03101%
Returns for 1 year17.955.93303%
Returns for 3 years4.55-15.70-29%
Returns for 5 years37.9911.48331%
Returns for 10 years46.4448.3096%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTRA27.440.61
+2.27%
Coterra Energy
USNA39.36-0.16
-0.40%
USANA Health Sciences
RDNT81.30-0.86
-1.05%
RadNet
AXDX1.67-0.03
-1.76%
Accelerate Diagnostics
TCRX3.94-0.18
-4.37%
TScan Therapeutics